The Arora Report

December 6, 2016

PLAN ON MYLAN: TEVA PHARMACEUTICAL, TAX LOSS SELLING AND TRUMP $MYL $TEVA

This post was just published on ZYX Buy Change Alert.

TEVA

MYL is a generic drug manufacturer. The earlier decline in the stock was in sympathy with TEVA. TEVA is the largest generic drug manufacturer in the world. TEVA’s head of generics unexpectedly departed. The market extrapolated that one reason for his departure could have been the weakness in TEVA’s generic business. It is a stretch to assume from TEVA news that MYL business is also under pressure. Initially the market has been running with this stretch. However this afternoon cooler heads seem to be prevailing and MYL stock is recovering.

… Please click here or the title below to read more.

December 6, 2016

SIRIUS XM HOLDINGS TOP CONTENDER TO BUY PANDORA, WHAT TO DO NOW $P $SIRI

This post was just published on ZYX Buy Change Alert.

P is long from $12.31. It is trading at $13.75 as of this writing.

There is a report that SIRI is the top contender to buy P.

P is an internet music service.

This continues to be suitable only for aggressive investors as the risk of loss is high.

This is a short-term trade, not an investment. Maximum recommended quantity is 35%. The new buy zone is $11.50 to $13.61, preferably below $12.81. Target zone remains $16 to $18. Mental stop is under $10.68.

What To Do Now

Those in the stock may continue to hold.

… Please click here or the title below to read more.

December 6, 2016